NDC 16714-826 – Propafenone hydrochloride
Propafenone Hydrochloride 325 mg/1 · Capsule, Extended Release · Oral
Product NDC16714-826
Product details
- Brand name
- Propafenone hydrochloride
- Generic name
- Propafenone hydrochloride
- Labeler
- Northstar Rx LLC
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA205268
- Marketed since
- March 31, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Antiarrhythmic
Active ingredients
- Propafenone Hydrochloride 325 mg/1
Uses, dosage, side effects and warnings for Propafenone hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 16714-826-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-826-01) | Jul 16, 2018 |
Recalls mentioning this NDC
- D-0351-2025 Apr 16, 2025 · Class II
CGMP Deviations - D-0352-2025 Apr 16, 2025 · Class II
CGMP Deviations
Other Propafenone hydrochloride products
- 59651-278 Propafenone Hydrochloride 425 mg/1 · Capsule, Extended Release · Aurobindo Pharma Limited
- 59651-276 Propafenone Hydrochloride 225 mg/1 · Capsule, Extended Release · Aurobindo Pharma Limited
- 59651-277 Propafenone Hydrochloride 325 mg/1 · Capsule, Extended Release · Aurobindo Pharma Limited
- 68462-410 Propafenone Hydrochloride 425 mg/1 · Capsule, Extended Release · Glenmark Pharmaceuticals Inc., USA
- 68462-408 Propafenone Hydrochloride 225 mg/1 · Capsule, Extended Release · Glenmark Pharmaceuticals Inc., USA
- 68462-409 Propafenone Hydrochloride 325 mg/1 · Capsule, Extended Release · Glenmark Pharmaceuticals Inc., USA
- 16714-825 Propafenone Hydrochloride 225 mg/1 · Capsule, Extended Release · Northstar Rx LLC
- 16714-827 Propafenone Hydrochloride 425 mg/1 · Capsule, Extended Release · Northstar Rx LLC
- 16571-736 Propafenone Hydrochloride 225 mg/1 · Capsule, Extended Release · Rising Pharma Holdings, Inc.
- 16571-737 Propafenone Hydrochloride 325 mg/1 · Capsule, Extended Release · Rising Pharma Holdings, Inc.
- 16571-738 Propafenone Hydrochloride 425 mg/1 · Capsule, Extended Release · Rising Pharma Holdings, Inc.
- 0832-0741 Propafenone Hydrochloride 325 mg/1 · Capsule, Extended Release · Upsher-Smith Laboratories, LLC